Ruxolitinib: a game changer in paediatric chronic graft-versus-host disease management?

被引：0
|
作者：
Sisinni, Luisa [1 ]
机构：
[1] La Paz Univ Hosp, Pediat HSCT Unit, Madrid 28046, Spain
来源：
LANCET HAEMATOLOGY | 2024年 / 11卷 / 08期
关键词：
CRITERIA; CHILDREN;
D O I：
10.1016/S2352-3026(24)00206-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：e553 / e555
页数：3
相关论文
共 50 条
  • [21] Ruxolitinib in the management of steroid-resistant/-dependent acute and chronic graft-versus-host disease: results of routine practice in an academic centre
    Leung, Garret M. K.
    Sim, Joycelyn P. Y.
    Hwang, Yu-Yan
    Chan, Thomas S. Y.
    Lie, Albert K. W.
    Tse, Eric
    Kwong, Yok-Lam
    ANNALS OF HEMATOLOGY, 2022, 101 (01) : 155 - 163
  • [22] Graft-versus-host disease
    Moreno, David F.
    Cid, Joan
    MEDICINA CLINICA, 2019, 152 (01): : 22 - 28
  • [23] Ruxolitinib Treatment in an Adolescent With Chronic Graft-Versus-Host Disease Mimicking Eosinophilic Gastrointestinal Disorders: A Case Report
    Getsuwan, Songpon
    Tanpowpong, Pornthep
    Hongeng, Suradej
    Anurathapan, Usanarat
    Pakakasama, Samart
    Treepongkaruna, Suporn
    TRANSPLANTATION PROCEEDINGS, 2022, 54 (06) : 1675 - 1678
  • [24] ANZTCT consensus position statement on ruxolitinib in steroid-refractory acute and chronic graft-versus-host disease
    Hamad, Nada
    Bilmon, Ian
    Chee, Lynette
    Henden, Andrea
    Johnston, Anna
    Purtill, Duncan
    Bajel, Ashish
    Tey, Siok-Keen
    Yeung, David
    Cole, Theresa
    Lewis, Clinton
    Butler, Jason
    INTERNAL MEDICINE JOURNAL, 2023, 53 (12) : 2319 - 2329
  • [25] A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease
    Bhatt, Vijaya Raj
    Shostrom, Valerie K.
    Choe, Hannah K.
    Hamilton, Betty K.
    Gundabolu, Krishna
    Maness, Lori J.
    Kumar, Virender
    Mahato, Ram I.
    Smith, Lynette M.
    Nishihori, Taiga
    Lee, Stephanie J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (33)
  • [26] Early Access for Medicines in ITALY: The Case of Ruxolitinib for Patients with Graft-Versus-Host Disease
    Gozzo, Lucia
    Leotta, Salvatore
    Romano, Giovanni Luca
    Vetro, Calogero
    Duminuco, Andrea
    Milone, Giuseppe
    Cupri, Alessandra
    Palumbo, Fanny Erika
    Brancati, Serena
    Ruscica, Rosy
    Longo, Laura
    Vitale, Daniela Cristina
    Fiorenza, Giorgia
    Lombardo, Giovanni Enrico
    Lazzara, Antonio
    Di Raimondo, Francesco
    Palumbo, Giuseppe Alberto
    Drago, Filippo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (14)
  • [27] Oral chronic graft-versus-host disease in Australia: clinical features and challenges in management
    Hull, K.
    Kerridge, I.
    Avery, S.
    McCullough, M.
    Ritchie, D.
    Szer, J.
    INTERNAL MEDICINE JOURNAL, 2015, 45 (07) : 702 - 710
  • [28] The role of extracorporeal photopheresis in chronic graft-versus-host disease
    Radojcic, Vedran
    Pletneva, Maria A.
    Couriel, Daniel R.
    TRANSFUSION AND APHERESIS SCIENCE, 2015, 52 (02) : 157 - +
  • [29] Tear Cytokines as Biomarkers for Chronic Graft-versus-Host Disease
    Jung, Ji Won
    Han, Soo Jung
    Song, Mi Kyung
    Kim, Tae-im
    Kim, Eung Kweon
    Min, Yoo Hong
    Cheong, June-Won
    Seo, Kyoung Yul
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (12) : 2079 - 2085
  • [30] Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
    Wolff, Daniel
    Cutler, Corey
    Lee, Stephanie J.
    Pusic, Iskra
    Bittencourt, Henrique
    White, Jennifer
    Hamadani, Mehdi
    Arai, Sally
    Salhotra, Amandeep
    Perez-Simon, Jose A.
    Alousi, Amin
    Choe, Hannah
    Kwon, Mi
    Bermudez, Arancha
    Kim, Inho
    Socie, Gerard
    Chhabra, Saurabh
    Radojcic, Vedran
    O'Toole, Timothy
    Tian, Chuan
    Ordentlich, Peter
    Defilipp, Zachariah
    Kitko, Carrie L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (11): : 1002 - 1014
12345